Publication

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Journal Contribution - Journal Article

BACKGROUND: We investigated prognostic factors (PFs) for 90-day mortality in a large cohort of advanced/metastatic soft tissue sarcoma (STS) patients treated with first-line chemotherapy.

Journal: British Journal of Cancer

ISSN: 0007-0920

Issue: 10

Volume: 104

Pages: 1544 - 1550

Publication year:2011

DOI: https://doi.org/10.1038/bjc.2011.136
Institutional Repository URL: https://lirias.kuleuven.be/1474007
WoS Id: 000290471600005
PubMed Id: 21505457

BOF-keylabel:yes

IOF-keylabel:yes

BOF-publication weight:2

CSS-citation score:1

Authors:International

Authors from:Higher Education

Publication

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Journal Contribution - Journal Article

Authors/publisher

Research units